This is a standard SPAC IPO filing. No adverse financial or operational news — the company has no operating business yet. Monitor for the Form 8-K with audited balance sheet post-closing and any subsequent definitive agreement announcement for a business combination target. The next catalyst will be identification of a target or, if no deal is announced within 24 months, a liquidation vote.
Price Chart
Executive Summary
Cartesian Growth Corp IV is a blank-check SPAC that filed an 8-K to provide its amended governing documents, an underwriting agreement for its IPO of 25,000,000 units at $10.00 per unit, and details on the private placement of warrants and founder shares. The filing also reflects officer/director appointments and bylaw amendments standard for a SPAC formation. This is a routine business combination company registration and IPO filing with no material financial results or operating business.
Key Financial Metrics
Key Facts
- Company filed an underwriting agreement with Cantor Fitzgerald for an IPO of 25,000,000 units at $10.00 per unit.
- Underwriters have an over-allotment option to purchase up to an additional 3,750,000 units.
- Each unit consists of one Class A ordinary share and one-third of one redeemable warrant with an exercise price of $11.50 per share.
- Proceeds from the IPO ($250M) and private placement will be deposited into a trust account pending a business combination.
- Sponsor CGC IV Sponsor LLC purchased 7,187,500 founder shares for $25,000 and will purchase 937,500 private placement warrants at $2.00 each.
- The Representative (Cantor Fitzgerald) will purchase 1,562,500 private placement warrants at $2.00 each.
- Deferred underwriting commission of $10.0M (4.0% of firm unit proceeds) plus up to $2.25M on option units will be held in trust and paid upon business combination.
- Company has a 24-month window to complete a business combination from IPO closing or it will redeem public shares and liquidate.
- Amended and restated memorandum and articles of association adopted June 24, 2026, outlining standard SPAC governance, including Class B share conversion rights and redemption mechanics.
- No target business has been selected or substantive discussions initiated as of the filing date.
Financial Impact
IPO raises $250M gross from firm units ($10.40 per unit net of underwriting discounts and deferred commission), with potential additional $37.5M from over-allotment. Private placement adds $5M from warrant sales. Total trust account expected to be $250M from firm IPO plus $2.5M from over-allotment option proceeds.
Risk Factors
- No identified business combination target — risk of liquidation if no deal within 24 months.
- Warrants may expire worthless if no business combination closes within 5 years.
- Founder shares are subject to lock-up and may be forfeited if over-allotment option not fully exercised.
- Dilution from warrant exercise and potential future equity-linked securities issuance.
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001185185-26-002727 |
| Document: cgcivex1-1.htm | 0001185185-26-002727 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 30, 2026 17w ago | 8-K | — | awaiting T+20 | — | — |
Jun 25, 2026 17w ago | 424B4 | — | awaiting T+20 | — | — |
Jun 25, 2026 17w ago | EFFECT | — | awaiting T+20 | — | — |
Jun 24, 2026 17w ago | 3 | — | awaiting T+20 | — | — |
Jun 24, 2026 17w ago | 3 | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers